Outcome of patients with amyotrophic lateral sclerosis attending in a multidisciplinary care unit;Evolución de pacientes con esclerosis lateral amiotrófica atendidos en una unidad multidisciplinar

Neurologia

Volumn 26, Issue 8, 2011, Pages 455-460

  Rodriguez de Rivera F J ^a   Oreja Guevara, C ^a   Sanz Gallego, I ^a   San Jose Valiente B ^a   Santiago Recuerda, A ^a   Gomez Mendieta M A ^a   Arpa, J ^a   Diez Tejedor E ^a  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

Author keywords

Amyotrophic lateral sclerosis; Multidisciplinary care unit; Outcome

Indexed keywords

ADULT; AMYOTROPHIC LATERAL SCLEROSIS; ARM; ARTICLE; CLINICAL ARTICLE; COGNITIVE DEFECT; DEPRESSION; DYSPHAGIA; FEMALE; FUNCTIONAL DISEASE; FUNCTIONAL STATUS; HUMAN; LEG; MALE; MORTALITY; OBSERVATIONAL STUDY; ONSET AGE; OUTCOME ASSESSMENT; PROSPECTIVE STUDY; RESPIRATORY TRACT DISEASE;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; DISEASE PROGRESSION; FEMALE; HOSPITAL UNITS; HUMANS; INTERPROFESSIONAL RELATIONS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SPAIN; TREATMENT OUTCOME;

EID: 80052944160     PISSN: 02134853     EISSN: 15781968     Source Type: Journal    
DOI: 10.1016/j.nrl.2011.01.021     Document Type: Article

References (30)

1. Chancellor A.M., Slattery J.M., Fraser H., Swingler R.J., Holloway S.M., Warlow C.P. The prognosis of adult-onset motor neuron disease: a prospective study based on the Scottish Motor Neuron Disease Register. J Neurol 1993, 240:339-346.
2. Rowland L.P., Shneider N.A. Amyotrophic lateral sclerosis. N Engl J Med 2001, 344:1688-1700.
3. Matías-Guiu J., García-Ramos G., Galán L., Vela A., Guerrero A. Analytic epidemiological information of amyotrophic lateral sclerosis. Neurologia 2008, 23:168-178.
4. Matias-Guiu J., Galán L., Garcia-Ramos R., Vela A., Guerrero A. Descriptive epidemiology of amyotrophic lateral sclerosis. Neurologia 2007, 22:368-380.
5. Bensimon G., Lacomblez L., Meininger V. A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS/Riluzole Study Group. N Engl J Med 1994, 330:585-591.
6. Bensimon G., Lacomblez L., Delumeau J.C., Bejuit R., Truffinet P., Meininger V. Riluzole/ALS Study Group II A study of riluzole in the treatment of advanced stage or elderly patients with amyotrophic lateral sclerosis. J Neurol 2002, 249:609-615.
7. Traynor B.J., Alexander M., Corr B., Frost E., Hardiman O. An outcome study of riluzole in amyotrophic lateral sclerosis-a population-based study in Ireland, 1996-2000. J Neurol 2003, 250:473-479.
8. World Federation of Neurology. ALS Research Centres, 2002. Disponible en: http://www.wfnals.org/clinics/index.html.
9. Chio A., Bottacchi E., Buffa C., Mutani R., Mora G. Positive effects of tertiary centres for amyotrophic lateral sclerosis on outcome and use of hospital facilities. J Neurol Neurosurg Psychiatry 2006, 77:948-950.
10. Aupperle P.M., Coyne A.C. Primary vs subspecialty care: a structured follow-up of dementia patients and their caregivers. Am J Geriatr Psychiatry 2000, 8:167-170.
11. Zoccolella S., Beghi E., Palagano G., Fraddosio A., Guerra V., et al. ALS multidisciplinary clinic and survival. Results from a population based study in Southern Italy. J Neurol 2007, 254:1107-1112.
12. Rodriguez de Rivera F.J., Grande M., García-Caballero J., Muñoz Blanco J., Mora J., Esteban J., et al. Developmentof a clinical pathway for the attention of patientswith amyotrophic lateral sclerosis in a regional network. ALS Assistance Network-Comunidad de Madrid. Neurologia 2007, 22:354-361.
13. Brooks B.R., Miller R.G., Swash M., Munsat T.L. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 2000, 1:293-299. World Federation of Neurology Research Group on Motor Neuron Diseases.
14. Gordon P.H., Miller R.G., Moore D.H. ALSFRS-R. Amyotroph Lateral Scler Other Motor Neuron Disord 2004, 5(Suppl1):90-93.
15. Karnell M.P., MacCracken E. A database information storage and reporting system for videofluorographic oropharyngeal motility (OPM) swallowing evaluations. Am J Speech Lang Pathol 1994, 3:54-60.
16. Hamilton M, Shapiro CM. Depression. En: Peck DF, Shapiro CM, editores. Measuring human problems: a practical guide. NewYork: Wiley; 1990. p. 27, 35, 184.
17. Rodríguez de Rivera F.J., Oreja Guevara C., Díez-Tejedor E. Efficiency of Multidisciplinary units and the application of clinical pathways in the care of ALS patients. Amyotrophic Lateral Sclerosis 2007, 8(Suppl1):106.
18. Traynor B.J., Alexander M., Corr B., Frost E., Hardiman O. Effect of a multidisciplinary amyotrophic lateral sclerosis (ALS) clinic on ALS survival: a population based study, 1996-2000. J Neurol Neurosurg Psychiatry 2003, 74:1258-1261.
19. Sabatelli M., Madia F., Conte A., Luigetti M., Zollino M., Mancuso I., et al. Natural history of Young-adult amyotrofic lateral sclerosis. Neurology 2008, 71:876-881.
20. Gouveia L., De Carvalho M. Young-onset sporadic amyotrophic lateral sclerosis: a distinct nosological entity?. Amyotroph Lateral Scler 2007, 8:323-327.
21. Zoccolella S., Beghi E., Palagano G., Fraddosio A., Guerra V., Samarelli V., et al. Predictors of long survival in amyotrophic lateral sclerosis: a population-based study. J Neurol Sci 2008, 268:28-32.
22. Miller R., Jackson C., Kasarskis E., England J., Forshew D., Johnston W., et al. Quality Standards Subcommittee of the American Academy of Neurology. Practice parameter update: The care of the patient with amyotrophic lateral sclerosis: Multidisciplinary care, symptom management, and cognitive/behavioral impairment (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2009, 73:1227-1233.
23. Andersen P.M., Borasio G.D., Dengler R., Hardiman O., Kollewe K., Leigh P.N., et al. EFNS Task Force on Diagnosis and Management of Amyotrophic Lateral Sclerosis EFNS task force on management of amyotrophic lateral sclerosis: guidelines for diagnosing and clinical care of patients and relatives. Eur J Neurol 2005, 12:921-938.
24. Bradley G.W., Anderson F., Bromberg M., Gutmann L, Harati Y, Ross M, et al. ALS CARE Study Group Current management of ALS Comparison of the ALS CARE Database and the AAN Practice Parameter. Neurology 2001, 57:500-504.
25. Gordon P., Cheng B., Salachas F., Pradat P.F., Bruneteau G., Corcia P., et al. Progression in ALS is not linear but is curvilinear. J Neurol 2010, 257:1713-1717.
26. Radunovic A., Mitsumoto H., Nigel Leigh P. Clinical care of patients with amyotrophic lateral sclerosis. Lancet Neurol 2007, 6:913-925.
27. Turner M.R., Parton M.J., Shaw C.E., Leigh P.N., Al-Chalabi A. Prolonged survival in motor neuron disease: a descriptive study of the King's database 1990-2002. J Neurol Neurosurg Psychiatry 2003, 74:995-997.
28. Turner M.R., Bakker M., Sham P., Shaw C.E., Leigh P.N., Al-Chalabi A. Prognostic modelling of therapeutic interventions in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 2002, 3:15-21.
29. Kurt A., Nijboer F., Matnz T., Kübler A. Depression and anxiety in individuals with ALS: epidemiology and management. CNS Drugs 2007, 21:279-291.
30. Frank B., Haas J., Heinze H.J., Stark E., Münte T.F. Relation of neuropsychological and magnetic resonance findings in ALS: evidence for subgroups. Clin Neurol Neurosurg 1997, 99:79-86.